Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infections
- 31 December 2004
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 24 (6), 567-571
- https://doi.org/10.1016/j.ijantimicag.2004.07.007
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in PennsylvaniaAntimicrobial Agents and Chemotherapy, 2004
- Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide EmergenceEmerging Infectious Diseases, 2003
- Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICsDiagnostic Microbiology and Infectious Disease, 2003
- Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance ProgramAnnals of Pharmacotherapy, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the CommunityJournal of Clinical Microbiology, 2002
- Epidemiology and Clonality of Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin Minnesota, 1996–1998Clinical Infectious Diseases, 2001
- Overcoming Bacterial Resistance by Dual Target Inhibition: The Case of StreptograminsCurrent Drug Targets - Infectious Disorders, 2001
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001